Form 4 · Filed Jun 2, 2026, 11:14 PM UTC
NRIX/Nurix Therapeutics, Inc.
Ring Christine — Chief Legal Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 2, 2026 | M | other | 3,422 | $2 | $6,365 | 21,727 |
| Jun 2, 2026 | S | sell | 8,148 | $17 | $135,253 | 13,579 |
| Jun 2, 2026 | M | other | 3,422 | — | — | 5,221 |
Source: SEC EDGAR raw filing ↗ · Accession 0001817199-26-000020